• Ironwood Pharmaceuticals appointed Chief Commercial Officer Tammi Gaskins CEO and a director, effective Jan. 1, 2027.
• Gaskins succeeds Tom McCourt, who will retire as CEO on that date.
• She joined the company in 2020 following a 20-year tenure at AstraZeneca, where she held commercial leadership roles.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ironwood Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261016751818) on October 16, 2026, and is solely responsible for the information contained therein.